Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 114.00
-3.00 (-2.56%)
Oct 6, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 4.95 billion as of October 6, 2026. Its market cap has decreased by -31.99% in one year.
Market Cap
4.95B
Enterprise Value
1.40B
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
114.00
ChartMarket Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 4.95B, a decrease of -83.98%. That is a compound annual growth rate of -42.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.95B | -14.09% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 6.53B |
| CellSource | 6.23B |
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |